Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 20496262)

1.

Development of therapeutic agents for older patients with acute myelogenous leukemia.

Hourigan CS, Karp JE.

Curr Opin Investig Drugs. 2010 Jun;11(6):669-77. Review.

PMID:
20496262
2.
3.

Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.

Tran H, Yang D.

Ann Pharmacother. 2012 Jan;46(1):89-96. doi: 10.1345/aph.1Q295. Epub 2011 Dec 13. Review.

PMID:
22170975
4.

Tipifarnib in acute myeloid leukemia.

Burnett AK, Kell J.

Drugs Today (Barc). 2007 Nov;43(11):795-800. doi: 10.1358/dot.2007.43.11.1088617.

PMID:
18174965
5.
6.

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights.

Zhu X, Ma Y, Liu D.

J Hematol Oncol. 2010 Apr 23;3:17. doi: 10.1186/1756-8722-3-17. Review.

7.

Current and emerging therapies for acute myeloid leukemia.

Robak T, Wierzbowska A.

Clin Ther. 2009;31 Pt 2:2349-70. doi: 10.1016/j.clinthera.2009.11.017. Review.

PMID:
20110045
8.

Has there been progress in the treatment of older patients with acute myeloid leukemia?

Erba HP.

Best Pract Res Clin Haematol. 2010 Dec;23(4):495-501. doi: 10.1016/j.beha.2010.09.012. Epub 2010 Nov 1. Review.

PMID:
21130413
9.

Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.

Kuendgen A, Germing U.

Cancer Treat Rev. 2009 Apr;35(2):97-120. doi: 10.1016/j.ctrv.2008.09.001. Epub 2008 Oct 31. Review.

PMID:
18951721
10.

The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia.

Fassas A, Anagnostopoulos A.

Leuk Lymphoma. 2005 Jun;46(6):795-802. Review.

PMID:
16019523
11.

Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity.

Robak T, Szmigielska-Kapłon A, Pluta A, Grzybowska-Izydorczyk O, Wolska A, Czemerska M, Wierzbowska A.

Curr Med Chem. 2011;18(5):638-66. Review.

PMID:
21182488
12.

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F, Henze G, Jürgens H, Kabisch H, Havers W, Reiter A, Kluba U, Niggli F, Gadner H.

J Clin Oncol. 2001 May 15;19(10):2705-13.

PMID:
11352963
13.

Novel agents for the treatment of acute myeloid leukemia in the older patient.

Baer MR, Gojo I.

J Natl Compr Canc Netw. 2011 Mar;9(3):331-5.

PMID:
21393442
14.

Farnesyltransferase inhibitor therapy in acute myelogenous leukemia.

Gotlib J.

Curr Hematol Rep. 2005 Jan;4(1):77-84. Review.

PMID:
15610664
15.

Acute myeloid leukemia in the elderly: current therapeutic results and perspectives for clinical research.

Ferrara F, Pinto A.

Rev Recent Clin Trials. 2007 Jan;2(1):33-41. Review.

PMID:
18473986
16.

Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.

Champlin R, Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W.

J Clin Oncol. 1990 Jul;8(7):1199-206.

PMID:
1694236
17.

Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine.

Visani G, Olivieri A, Malagola M, Brunori M, Piccaluga PP, Capelli D, Pomponio G, Martinelli G, Isidori A, Sparaventi G, Leoni P.

Leuk Lymphoma. 2006 Jun;47(6):1091-102.

PMID:
16840201
18.

Mitoxantrone in the treatment of acute myelogenous leukemia: a review.

Thomas X, Archimbaud E.

Hematol Cell Ther. 1997 Aug;39(4):63-74. Review.

PMID:
9352324
19.

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.

Bross PF, Beitz J, Chen G, Chen XH, Duffy E, Kieffer L, Roy S, Sridhara R, Rahman A, Williams G, Pazdur R.

Clin Cancer Res. 2001 Jun;7(6):1490-6. Erratum in: Clin Cancer Res 2002 Jan;8(1):300.

20.

The role of timed sequential chemotherapy in adult acute myelogenous leukemia.

Thomas X.

Curr Hematol Malig Rep. 2008 Apr;3(2):89-95. doi: 10.1007/s11899-008-0014-x. Review.

PMID:
20425452
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk